Results 61 to 70 of about 28,791 (228)
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Aortic stenosis (AS) is associated with a heightened burden of cardiovascular comorbidities, atrial fibrillation (AF), and progressive valvular calcification, all of which may contribute to cerebrovascular events across the disease continuum.
Priyanka Boettger +7 more
wiley +1 more source
Predicting mortality after transcatheter aortic valve replacement external validation of the Transcatheter Valve Therapy registry model [PDF]
, 2017 BACKGROUND: The Transcatheter Valve Therapy (TVT) registry model was recently developed to predict the risk of in-hospital mortality in patients undergoing transcatheter aortic valve replacement.
Oliver Muller +34 more
core +1 more source
Bicuspid Aortic Valve Morphology and Outcomes After Transcatheter Aortic Valve Replacement. [PDF]
, 2020 BACKGROUND Bicuspid aortic stenosis accounts for almost 50% of patients undergoing surgical aortic valve replacement in the younger patients. Expanding the indication of transcatheter aortic valve replacement (TAVR) toward lower-risk and younger ...
Makkar, Raj R +54 more
core +1 more source
Transcatheter Aortic Valve Replacement and Stroke [PDF]
Circulation: Cardiovascular Interventions, 2015 The evaluation of any therapy includes an assessment of benefits and risks. For percutaneous coronary interventions, death and myocardial infarction are typically selected as the 2 hard end points for describing adverse events. Stroke may be observed during percutaneous coronary intervention and be a direct result of the procedure.
Neil J, Wimmer, David O, Williams
openaire +2 more sources
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Background The EMPIRE I study assessed the early (30 days) safety and efficacy of a new fully repositionable delivery system (IMPERIA) for the commercially available ALLEGRA transcatheter aortic valve in patients with either severe native aortic stenosis or a degenerated surgical bioprosthesis.
José Antonio Baz +15 more
wiley +1 more source
Pathophysiologic Consequences of Early Coarctation Stenting in a Longitudinal Porcine Model
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Background Novel stent technologies offer early intravascular treatment options for coarctation (COA). Mid‐to‐long‐term cardiovascular responses to early COA stent interventions are undefined. Aims We studied a porcine model of COA, with and without early stent implantation with serial dilation to adult aortic diameters, aiming to define ...
Leah M. Gober +7 more
wiley +1 more source
Catheterization and Cardiovascular Interventions, EarlyView.Methodological framework among international observers to understand clinical decision‐making and interobserver agreement in TPVR planning. ABSTRACT Background Transcatheter pulmonary valve replacement (TPVR) requires selecting the optimal device type, size, and position. Variability in anatomical shape may affect procedural planning.
Camilo E. Pérez‐Cualtán +10 more
wiley +1 more source
Transcatheter Aortic Valve Replacement (TAVR) [PDF]
, 2021 Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement in Treatment of Aortic Valve Stenosis Ashlee Blannett Faculty Mentor: Lorie Zelna, M.S., R.T.
Blannett, Ashlee
core +1 more source
Transcatheter Aortic Valve Replacement [PDF]
, 2023 Transcatheter aortic valve replacement(TAVR) is a catheter‐based aortic valve replacement. It is primarily used to treat severe degenerative aortic valve stenosis. The first TAVR was performed in humans in 2002.
Alfonso, Carlos E, Seifu, Solomon A
core +1 more source
JACC: Case Reports, 2020 This report describes a successful transcatheter aortic valve replacement in an older patient with severe aortic stenosis, mitral paravalvular leak, and associated hemolytic anemia.
Hideaki Kanzaki, MD, PhD +7 more
doaj +1 more source